United States News All stories

Vertex Pharmaceuticals (NASDAQ:VRTX) reported positive Phase 2b AMPLIFIED study results for inaxaplin in people with APOL1-mediated kidney disease and different levels of proteinuria.

Ionis Pharmaceuticals (NASDAQ:IONS) and Otsuka Pharmaceutical reported positive topline Phase 3 results for ulefnersen, an investigational RNA-targeted medicine for FUS-ALS.

Ligand Pharmaceuticals (NASDAQ:LGND) agreed to acquire royalty and milestone interests in Santen’s Ryjunea eye drop for a $23 million upfront payment.

Lexeo Therapeutics (NASDAQ:LXEO) agreed to acquire Mantle Therapeutics for up to $21.3 million to expand its Friedreich ataxia drug development portfolio.

GameStop (NYSE:GME) shares rose after CEO Ryan Cohen disclosed the purchase of approximately 1.15 million additional shares worth about $26.4 million.

MediWound (NASDAQ:MDWD) received an additional $3.3 million in non-dilutive funding to support development of a room-temperature-stable NexoBrid formulation for battlefield burn care.

Cognex Corporation (NASDAQ:CGNX) announced a definitive agreement to acquire RealSense, a provider of 3D robotic perception and depth-sensing camera technology, for approximately $500 million in cash.

Viking Therapeutics (NASDAQ:VKTX) announced positive topline results from a 33-week clinical study evaluating VK2735, its investigational GLP-1/GIP receptor agonist being developed for obesity treatment.

MillerKnoll (NASDAQ:MLKN) reported financial results for the first quarter of fiscal year 2027, showing improved profitability and order growth despite a decline in revenue.

AutoZone (NYSE:AZO) reported fourth-quarter and full fiscal year 2026 financial results, showing higher sales, improved profitability and continued expansion of its automotive aftermarket retail footprint.

NielsenIQ (NYSE:NIQ) announced that its Australian subsidiary, Nielsen Connect Australia, has launched a conditional off-market takeover offer for all outstanding shares of The U Group & Co Limited.

Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) approved an update to the U.S. prescribing information for WINREVAIR™ (sotatercept-csrk).

U.S. GoldMining (NASDAQ:USGO) announced the completion of its 2026 drill program at the Whistler Gold-Copper Project in Alaska, marking the largest exploration campaign conducted by the company since its formation.

THOR Industries (NYSE:THO) reported fiscal 2026 fourth-quarter and full-year financial results, showing lower earnings as the company navigated weaker North American RV demand, margin pressure and restructuring initiatives.

Alpha Compute (NASDAQ:ALP) announced that it has entered into binding real estate and asset purchase agreements to acquire an operating oil and gas business in Pennsylvania for approximately $5.5 million.

Beam Global (NASDAQ:BEEM) announced that it has entered into a non-binding Letter of Intent to acquire a European drone technology company specializing in drone development, manufacturing and AI-enhanced drone software.

Summit Therapeutics (NASDAQ:SMMT) announced that data from the Phase III HARMONi-GI1 trial evaluating ivonescimab, a potential first-in-class investigational bispecific antibody, will be presented at the Presidential Symposium II during the European Society for Medical Oncology (ESMO) 2026 Congress.

Vicor Corporation (NASDAQ:VICR) shares moved higher in premarket trading after the modular power components manufacturer raised its third-quarter growth outlook, citing royalty income from a recently announced licensing agreement.

Here Group (NASDAQ:HERE) reported unaudited financial results for the fourth quarter and full fiscal year ended June 30, 2026, highlighting revenue growth from its expanding pop toy business and announcing corporate leadership changes.

TC Energy (NYSE:TRP) announced an agreement to sell Energía Occidente de México, the owner of the Guadalajara-Manzanillo Pipeline, to affiliates of ESENTIA for approximately $560 million.

Kanzhun (NASDAQ:BZ) announced that its board of directors has declared an annual cash dividend totaling approximately US$230 million to shareholders.

KKR (NYSE:KKR) and Mirastar, KKR Real Estate’s European industrial and logistics platform, have acquired a portfolio of eight UK logistics assets from funds managed by Ares Management Corporation Real Estate.

Pharming Group (NASDAQ:PHAR) announced positive topline results from a Phase II study evaluating leniolisib in patients with genetically identifiable primary immunodeficiencies (PIDs) associated with immune dysregulation caused by PI3Kδ signaling abnormalities.

AbbVie (NYSE:ABBV) announced that the European Commission has approved RINVOQ® (upadacitinib) 15 mg tablets and 1 mg/mL oral solution for the treatment of active polyarticular juvenile idiopathic arthritis (pJIA).